文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

黄芩苷对肝脏疾病的药理作用:综述

Pharmacological properties of baicalin on liver diseases: a narrative review.

机构信息

Department of Pharmacy, Tongji Hospital Affiliated Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang avenue, Wuhan, 430030, Hubei, China.

出版信息

Pharmacol Rep. 2021 Oct;73(5):1230-1239. doi: 10.1007/s43440-021-00227-1. Epub 2021 Feb 17.


DOI:10.1007/s43440-021-00227-1
PMID:33595821
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8460515/
Abstract

Baicalin is the main active component of Scutellaria baicalensis, widely used in traditional Chinese medicine thanks to its various pharmacological effects, such as anti-tumor, anti-inflammatory, and antibacterial properties, as well as cardiovascular, hepatic, and renal protective effect. Recently, the protective effects of baicalin on liver disease have received much more attention. Several studies showed that baicalin protects against several types of liver diseases including viral hepatitis, fatty liver disease, xenobiotic induced liver injury, cholestatic liver injury, and hepatocellular carcinoma, with a variety of pharmacological mechanisms. A comprehensive understanding of the mechanism of baicalin can provide a valuable reference for its clinical use, but up to now, no narrative review is available that summarizes the pharmacological effects of baicalin to clarify its potential use in the treatment of liver diseases. Therefore, this review summarizes the progress of baicalin research and the underlying mechanism in the treatment of various liver diseases, to promote further research and its clinical application.

摘要

黄芩苷是黄芩的主要活性成分,由于其具有多种药理作用,如抗肿瘤、抗炎和抗菌作用,以及心血管、肝脏和肾脏保护作用,在中国传统医学中被广泛应用。最近,黄芩苷对肝病的保护作用受到了更多的关注。多项研究表明,黄芩苷可预防多种类型的肝病,包括病毒性肝炎、脂肪肝、外源化合物诱导的肝损伤、胆汁淤积性肝损伤和肝癌,具有多种药理机制。全面了解黄芩苷的作用机制可为其临床应用提供有价值的参考,但到目前为止,尚无综述性评论总结黄芩苷的药理作用,以阐明其在治疗肝病方面的潜在用途。因此,本综述总结了黄芩苷在治疗各种肝病中的研究进展及其潜在机制,以促进进一步的研究及其临床应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7020/8460515/9df5adf29d3a/43440_2021_227_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7020/8460515/07efc0952cd9/43440_2021_227_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7020/8460515/9df5adf29d3a/43440_2021_227_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7020/8460515/07efc0952cd9/43440_2021_227_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7020/8460515/9df5adf29d3a/43440_2021_227_Fig2_HTML.jpg

相似文献

[1]
Pharmacological properties of baicalin on liver diseases: a narrative review.

Pharmacol Rep. 2021-10

[2]
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects.

Pharmacol Res. 2021-3

[3]
Effect of baicalin on toll-like receptor 4-mediated ischemia/reperfusion inflammatory responses in alcoholic fatty liver condition.

Toxicol Appl Pharmacol. 2011-10-14

[4]
Role of baicalin as a potential therapeutic agent in hepatobiliary and gastrointestinal disorders: A review.

World J Gastroenterol. 2022-7-14

[5]
Baicalin from Scutellaria baicalensis impairs Th1 polarization through inhibition of dendritic cell maturation.

J Pharmacol Sci. 2013

[6]
Therapeutic Mechanism of Baicalin in Experimental Colitis Analyzed Using Network Pharmacology and Metabolomics.

Drug Des Devel Ther. 2023

[7]
Protective effect of baicalin against lipopolysaccharide/D-galactosamine-induced liver injury in mice by up-regulation of heme oxygenase-1.

Eur J Pharmacol. 2008-6-10

[8]
Baicalin Protects against TNF-α-Induced Injury by Down-Regulating miR-191a That Targets the Tight Junction Protein ZO-1 in IEC-6 Cells.

Biol Pharm Bull. 2017-4-1

[9]
Baicalin relaxes vascular smooth muscle and lowers blood pressure in spontaneously hypertensive rats.

Biomed Pharmacother. 2018-12-24

[10]
[Study of Scutellaria baicalensis and Baicalin against antimicrobial susceptibility of Helicobacter pylori strains in vitro].

Zhong Yao Cai. 2008-5

引用本文的文献

[1]
Effects of Dietary Baicalin on Aflatoxin B1-Induced Growth Performance and Liver Health in Ducklings.

Animals (Basel). 2025-8-8

[2]
Antibacterial activity of baicalein against : and evaluation.

Front Microbiol. 2025-7-14

[3]
Targeting Urease: A Promising Adjuvant Strategy for Effective Eradication.

ACS Omega. 2025-7-4

[4]
Chinese medicine monomers for hepatocellular carcinoma: New ideas related to autophagy.

World J Gastroenterol. 2025-7-14

[5]
Liver disorders and phytotherapy.

Toxicol Rep. 2025-5-10

[6]
Advances in the role of baicalin and baicalein in colon cancer: mechanisms and therapeutic potential.

Discov Oncol. 2025-5-22

[7]
Oxidative stress modulation in alcohol-related liver disease: From chinese botanical drugs to exercise-based interventions.

Front Pharmacol. 2025-4-25

[8]
Evaluation of the Inhibitory Potential of Apigenin and Related Flavonoids on Various Proteins Associated with Human Diseases Using AutoDock.

Int J Mol Sci. 2025-3-12

[9]
Baicalin plays a protective role by regulating ferroptosis in multiple diseases.

Naunyn Schmiedebergs Arch Pharmacol. 2025-5

[10]
The therapeutic effects of Paeoniae Radix Rubra on chronic hepatitis through network pharmacology and molecular docking.

Medicine (Baltimore). 2024-12-6

本文引用的文献

[1]
HUCMSCs transplantation combined with ultrashort wave therapy attenuates neuroinflammation in spinal cord injury through NUR77/ NF-κB pathway.

Life Sci. 2021-2-15

[2]
Bioassay-guided isolation of anti-inflammatory constituents from Celtis sinensis leaves.

J Food Biochem. 2021-1

[3]
Applications, phytochemistry, pharmacological effects, pharmacokinetics, toxicity of Georgi. and its probably potential therapeutic effects on COVID-19: a review.

Chin Med. 2020-9-25

[4]
Liraglutide ameliorates obesity-related nonalcoholic fatty liver disease by regulating Sestrin2-mediated Nrf2/HO-1 pathway.

Biochem Biophys Res Commun. 2020-3-12

[5]
Baicalin Protects Against 17α-Ethinylestradiol-Induced Cholestasis the Sirtuin 1/Hepatic Nuclear Receptor-1α/Farnesoid X Receptor Pathway.

Front Pharmacol. 2020-2-11

[6]
Baicalin attenuates hepatic injury in non-alcoholic steatohepatitis cell model by suppressing inflammasome-dependent GSDMD-mediated cell pyroptosis.

Int Immunopharmacol. 2020-4

[7]
Baicalin and its aglycone: a novel approach for treatment of metabolic disorders.

Pharmacol Rep. 2020-1-8

[8]
Toll-like receptor 4 is a therapeutic target for prevention and treatment of liver failure.

J Hepatol. 2020-7

[9]
Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice.

Int Immunopharmacol. 2020-3

[10]
The Evolving Role of Neutrophils in Liver Transplant Ischemia-Reperfusion Injury.

Curr Transplant Rep. 2019

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索